SCHEMBL4876866

SCHEMBL4876866

Cc1ccc(S(=O)(=O)Oc2nc(N)nc3c2CCCCCc2ccccc2-3)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.46
CYP2C19 P33261 2/20 0.44
KEAP1 Q14145 1/20 0.43
NFE2L2 Q16236 1/20 0.43
HRH4 Q9H3N8 6/20 0.41
BCHE P06276 1/20 0.39
HRH2 P25021 1/20 0.39
HRH1 P35367 1/20 0.39
HRH3 Q9Y5N1 1/20 0.39
ADORA2A P29274 1/20 0.37
ADORA1 P30542 1/20 0.37
IKBKB O14920 1/20 0.36
KDM4E B2RXH2 2/20 0.36
POLB P06746 1/20 0.36
NPC1 O15118 1/20 0.35
MAPT P10636 1/20 0.35
MAPK1 P28482 1/20 0.35
RECQL P46063 1/20 0.35
RAB9A P51151 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4878194 0.99 ALDH1A1 (0.47) ALDH1A1CYP2C19KEAP1NFE2L2HRH4
SCHEMBL2166315 0.97 ALDH1A1 (0.49) ALDH1A1CYP2C19KEAP1NFE2L2HRH4
SCHEMBL4875369 0.83 HRH4 (0.48) ALDH1A1CYP2C19KEAP1NFE2L2HRH4
SCHEMBL4874187 0.82 ALDH1A1 (0.47) ALDH1A1CYP2C19KEAP1NFE2L2HRH4
SCHEMBL4129860 0.81 CYP2C19 (0.61) ALDH1A1CYP2C19KEAP1NFE2L2BCHE
SCHEMBL4877590 0.81 CYP2C19 (0.51) ALDH1A1CYP2C19KEAP1NFE2L2HRH2
SCHEMBL4874124 0.80 ALDH1A1 (0.51) ALDH1A1CYP2C19KEAP1NFE2L2IKBKB
SCHEMBL3128908 0.79 CYP2C19 (0.47) ALDH1A1CYP2C19KEAP1NFE2L2HRH2
SCHEMBL3131985 0.79 CYP2C19 (0.47) ALDH1A1CYP2C19KEAP1NFE2L2HRH2
SCHEMBL3135449 0.78 CYP2C19 (0.47) ALDH1A1CYP2C19KEAP1NFE2L2HRH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8735411-B2 Macrocyclic benzofused pyrimidine derivatives ABBVIE INC. (US) 2014-05-27 US disclosed
US-20080188452-A1 Macrocyclic Benzofused Pyrimidine Derivatives ABBVIE INC. 2008-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080188452-A1 Macrocyclic Benzofused Pyrimidine Derivatives DPYD, TYMS, UMPS ALDH1A1 411/4885CYP2C19 685/4885KEAP1 403/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.